Diagnosing acromegaly requires a combination of blood tests and imaging, typically starting with a single blood draw and progressing to a confirmatory test and then a brain scan. The process is straightforward once a doctor suspects the condition, but getting to that point of suspicion is often the real bottleneck. On average, patients live with symptoms for about 5.5 years before receiving a diagnosis, largely because the physical changes happen so gradually that they’re easy to miss.
Why Diagnosis Takes So Long
Acromegaly causes slow, incremental changes to the hands, feet, and face over years. You might notice your rings feel tighter or your shoes no longer fit, but these shifts happen so gradually that neither you nor the people around you register them as abnormal. Doctors who see you once a year may not notice either. The condition is rare enough that most primary care physicians will encounter only a handful of cases in their careers, so the physical signs don’t always trigger immediate suspicion.
Most diagnoses happen when a patient develops a related problem, like joint pain, sleep apnea, or diabetes, and a clinician starts investigating the underlying cause. Sometimes an old photograph compared to a recent one is what finally raises the question.
Step 1: The IGF-1 Blood Test
The first test is a simple blood draw measuring a hormone called IGF-1 (insulin-like growth factor 1). Your liver produces IGF-1 in response to growth hormone, so when growth hormone levels are chronically elevated, IGF-1 rises too. The key advantage of testing IGF-1 instead of growth hormone directly is stability: IGF-1 levels stay relatively constant throughout the day, giving a reliable snapshot from a single blood sample.
A single random measurement of growth hormone itself is not useful for diagnosis. Growth hormone is released in pulses throughout the day, has a short half-life, and the levels in people with acromegaly overlap with normal values at certain times. You could draw blood during a low point and get a falsely reassuring number. IGF-1 avoids this problem entirely. A high IGF-1 level, adjusted for your age and sex, is a strong marker pointing toward acromegaly and warrants further testing.
Step 2: The Glucose Suppression Test
If your IGF-1 comes back elevated, the next step is a confirmatory test called an oral glucose tolerance test. You drink a sugary solution containing 75 grams of glucose, and your blood is drawn at intervals over the next two hours to measure growth hormone levels. In a healthy person, the sugar load suppresses growth hormone to less than 1 ng/mL. In someone with acromegaly, growth hormone stays stubbornly elevated because the pituitary tumor producing it doesn’t respond to the normal signals that should shut it off.
This test is considered the gold standard for confirming the diagnosis. If your growth hormone fails to suppress after the glucose drink and your IGF-1 is elevated, the biochemical diagnosis is essentially confirmed.
Step 3: Pituitary MRI
Once blood tests confirm excess growth hormone, the next step is finding the source. In the vast majority of cases, that source is a benign tumor (adenoma) in the pituitary gland, a pea-sized structure at the base of the brain. A high-resolution MRI with contrast dye is the standard imaging tool. The contrast agent helps distinguish the tumor from surrounding normal pituitary tissue, since the adenoma and the healthy gland light up differently on the scan.
About 71% of acromegaly patients have macroadenomas, meaning tumors larger than 10 mm. The most common size range is 11 to 20 mm, found in roughly 45% of patients in a large study of nearly 300 cases. Smaller tumors (microadenomas, 10 mm or less) account for the remaining cases and can be harder to spot, sometimes requiring specialized MRI sequences to detect.
When No Tumor Is Visible
Occasionally, the MRI doesn’t show a clear pituitary tumor, or it shows something ambiguous that could be either a small adenoma or an enlarged pituitary gland. In these cases, doctors consider the possibility that the excess growth hormone is being driven by a signal from somewhere else in the body. Rarely, tumors in the lungs, pancreas, or other organs produce a hormone called GHRH that overstimulates the pituitary, causing it to enlarge and overproduce growth hormone. Measuring GHRH levels in the blood can identify this pattern and redirect the diagnostic search to the correct location.
Acromegaly vs. Gigantism
The diagnostic workup is essentially the same for both conditions. The difference is timing. Gigantism occurs when excess growth hormone begins before puberty, while the growth plates in bones are still open. This leads to unusual height and very long limbs. Acromegaly develops after puberty, when the growth plates have already closed, so instead of growing taller, bones thicken and widen, particularly in the hands, feet, and jaw.
Screening for Related Health Problems
Diagnosis doesn’t stop with confirming the tumor. Excess growth hormone affects nearly every organ system, often for years before anyone catches it. At the time of diagnosis, your doctors will typically screen for several complications that may have already developed.
- Colonoscopy: Expert consensus recommends a colonoscopy at diagnosis because acromegaly increases the risk of colon polyps and colorectal cancer.
- Blood pressure monitoring: High blood pressure is common and should be checked at diagnosis, then every six months going forward.
- Heart evaluation: Prolonged growth hormone excess can thicken the heart muscle and affect its function.
- Sleep study: Sleep apnea is very common in acromegaly, partly because soft tissue growth narrows the airway.
- Metabolic screening: Blood sugar and cholesterol levels are checked, since acromegaly frequently causes diabetes and abnormal lipid levels.
- Pituitary hormone panel: The tumor can compress normal pituitary tissue, disrupting production of other hormones like thyroid hormone, cortisol, and sex hormones.
These screenings are a critical part of the diagnostic picture because they shape the urgency and scope of treatment. Someone diagnosed with acromegaly and no complications has a different clinical situation than someone who already has heart enlargement, uncontrolled diabetes, and sleep apnea. The comorbidity profile at diagnosis often matters as much as the tumor itself in guiding what happens next.